Skip to content

Sagimet Biosciences

US · SGMT #3599 by market cap Listed 2023
8.72 -0.16 -1.80%
Live - 5344 symbols - heartbeat 408s ago · 2026-10-08 10:00
Pre-market 8.83 -0.56%
After-hours 8.88 0.00%
Market cap
618.32M
P/B
2.41
EPS
-1.58
Reader sentiment Are you bullish or bearish on SGMT?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    JonesTrading Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $31
    Market Newswire · 2026/9/28
  • A Quick Look at Today's Ratings for Sagimet Biosciences(SGMT.US), With a Forecast Between $25.1 to $56
    Market Newswire · 2026/10/1
  • Rating change
    Goldman Sachs Initiates Sagimet Biosciences(SGMT.US) With Sell Rating, Announces Target Price $7
    Market Newswire · 2026/9/24
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Sagimet Biosciences, Inc. Class A (SGMT) and Jade Biosciences (JBIO)
    TipRanks · 2026/10/1
  • H.C. Wainwright Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $29
    Market Newswire · 2026/10/5
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Sagimet Biosciences, Inc. Class A (SGMT) and Liquidia Technologies (LQDA)
    TipRanks · 2026/10/1
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Larimar Therapeutics (LRMR) and Sagimet Biosciences, Inc. Class A (SGMT)
    TipRanks · 2026/9/28
  • Rating change
    Sagimet Biosciences, Inc. Class A (SGMT) Receives a Buy From Cantor Fitzgerald
    TipRanks · 2026/10/1
  • Rating change
    Leerink Partners Maintains Sagimet Biosciences(SGMT.US) With Buy Rating
    Market Newswire · 2026/10/2
  • Rating change
    Analysts Offer Insights on Healthcare Companies: ProQR (PRQR) and Sagimet Biosciences, Inc. Class A (SGMT)
    TipRanks · 2026/10/1
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Sagimet Biosciences, Inc. Class A (SGMT) and Eli Lilly & Co (LLY)
    TipRanks · 2026/10/1
  • Analysts Are Bullish on Top Healthcare Stocks: Monte Rosa Therapeutics (GLUE), Sagimet Biosciences, Inc. Class A (SGMT)
    TipRanks · 2026/10/5
  • Rating change
    A Quick Look at Today's Ratings for Sagimet Biosciences(SGMT.US), With a Forecast Between $25 to $49
    Market Newswire · 2026/8/12
  • Goldman Sachs Maintains Sagimet Biosciences(SGMT.US) With Sell Rating, Maintains Target Price $7
    Market Newswire · 2026/10/1
  • Guggenheim Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Raises Target Price to $26
    Market Newswire · 2026/10/2
  • Rating change
    Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Sagimet Biosciences, Inc. Class A (SGMT)
    TipRanks · 2026/8/25
  • Rating change
    Barclays Upgrades Sagimet Biosciences(SGMT.US) to Buy Rating, Raises Target Price to $18
    Market Newswire · 2026/9/9
  • Rating change
    Cantor Fitzgerald Initiates Sagimet Biosciences(SGMT.US) With Buy Rating, Announces Target Price $26
    Market Newswire · 2026/9/9
  • Rating change
    Oppenheimer Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Raises Target Price to $38
    Market Newswire · 2026/10/1
  • Rating change
    Oppenheimer Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $33
    Market Newswire · 2026/8/12

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 10:00:18 · For reference only, not investment advice and not tailored to your situation.